Stephen D. Nimer, M.D., Inducted into Association of American Physicians
For the sixth year in a row, a University of Miami Miller School of Medicine faculty member has been inducted into the prestigious Association of American Physicians (AAP), whose members include Nobel laureates and world-renowned researchers and clinicians.
This year’s Miller School honoree is Stephen D. Nimer, M.D., Director of the Sylvester Comprehensive Cancer Center, and a visionary physician and scientist. He was inducted April 27 during the AAP’s annual meeting and dinner in Chicago. The association has been dedicated to “the advancement of scientific and practical medicine” since its founding in 1885.
“We are exceedingly proud to have yet another Miller School faculty member inducted into the AAP,” said Pascal J. Goldschmidt, M.D., Senior Vice President for Medical Affairs and Dean of the Miller School, and CEO of UHealth. “Dr. Nimer is one of the world’s premier leukemia and bone marrow derived stem cell transplant researchers and an exceptional physician who brings a true patient-centered approach to clinical care.”
Board certified in internal medicine, medical oncology and hematology, Nimer has more than 30 years of pioneering research and clinical experience. He has conducted extensive clinical and basic science research into the treatment and genetic basis of adult leukemia and bone marrow failure states, defining the regulatory mechanisms that control the production of blood cells and exploring new methods to treat cancers of the hematopoietic system. He is also known for his clinical expertise and laser-like focus on treating each patient as an individual.
“It is a great honor to be elected to the American Association of Physicians,” said Nimer, “as it allows me to sit alongside my teachers, my mentors, my heroes and my peers, based on our contributions to medicine as physicians.”
The recipient of numerous awards for his research and the author of more than 200 scientific publications, Nimer has been featured in several books about patients and their doctors, including “How Doctors Think.”
Since taking the helm of Sylvester, Nimer has recruited several top-notch scientists and clinicians to join the cancer center and build up some key programs; among the new additions are experts in sarcoma, leukemia, ocular melanoma and robotic surgery for bladder and prostate cancer. He is well on his way to realizing his vision of the cancer center as a medical destination and a supportive and stimulating work environment that will draw patients and premier physicians.
The cancer center is focused on building up its outreach to and education of the community, as well as advancing the prevention, early detection and care of cancer.
Before joining Sylvester, Nimer headed the Division of Hematologic Oncology at Memorial Sloan-Kettering Cancer Center. During nearly two decades there, he established the inpatient hematology service and the autologous stem cell transplant program for adults with hematologic malignancies. He participated in the pivotal clinical trials that led to the FDA approval of lenalidomide for 5q-myelodysplastic syndromes (MDS), and of decitabine for intermediate or high-risk MDS patients.
Furthermore, he and his laboratory team established several novel research programs identifying signaling pathways that could be targeted to treat patients with myeloid malignancies, such as acute myelogenous leukemia. They also focused on determining how cancer cells resist chemotherapy or radiation therapy.
Nimer was elected to the prestigious American Society of Clinical Investigators at age 42. He is also a fellow of the American College of Physicians and serves on the editorial board of several medical journals, and on the medical boards of several foundations, including the Aplastic Anemia and MDS International Foundation, the Bone Marrow Foundation, and the Myelodysplastic Syndrome Foundation, which he chairs.
Last year, Michael D. Norenberg, M.D., professor of pathology and biochemistry and molecular biology and director of neuropathology research, was inducted into AAP, and in 2011 UM’s Margaret Fischl, M.D., professor of medicine, Director of the AIDS Clinical Research Unit and co-director of the Miami Center for AIDS Research, and Joshua Hare, M.D., Louis Lemberg Professor of Medicine and Director of the Interdisciplinary Stem Cell Institute, were both inducted into the AAP.